Skip to main navigation Skip to search Skip to main content

Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology

  • Margaret von Mehren
  • , R. Lor Randall
  • , Robert S. Benjamin
  • , Sarah Boles
  • , Marilyn M. Bui
  • , Kristen N. Ganjoo
  • , Suzanne George
  • , Ricardo J. Gonzalez
  • , Martin J. Heslin
  • , John M. Kane
  • , Vicki Keedy
  • , Edward Kim
  • , Henry Koon
  • , Joel Mayerson
  • , Martin McCarter
  • , Sean V. McGarry
  • , Christian Meyer
  • , Zachary S. Morris
  • , Richard J. O'donnell
  • , Alberto S. Pappo
  • I. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, DJ Riedel, Bernice Ruo, Scott Schuetze, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, Jillian L. Scavone
  • University of Utah
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Oregon Health and Science University
  • University of California at San Diego
  • University of South Florida
  • Stanford University
  • Fox Chase Cancer Center
  • Stanford Medical Institute
  • Division of Oncology
  • Dana-Farber Cancer Institute
  • Dana-Farber/Brigham and Women's Cancer Center
  • Harvard University
  • Monash University
  • Boston Children's Hospital
  • St. Jude Children's Research Center
  • Memorial Sloan-Kettering Cancer Center
  • Dana-Farber/Harvard Cancer Center
  • University of Alabama at Birmingham
  • Roswell Park Comprehensive Cancer Center
  • Roswell Park Cancer Institute
  • Tel Aviv Sourasky Medical Center
  • Chicago Consensus Working Group
  • Vanderbilt University
  • Seattle Cancer Care Alliance
  • Fred Hutchinson Cancer Research Center
  • Case Western Reserve University
  • Ohio State University
  • University of Colorado Anschutz Medical Campus
  • University of Colorado
  • University of Colorado Cancer Center
  • University of Nebraska Medical Center
  • Nebraska Medicine
  • Johns Hopkins University
  • University of Wisconsin-Madison
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of California at San Francisco
  • University of Colorado Hospital/Memorial Hospital/Medical Center of Rockies
  • University of Tennessee Health Science Center
  • St. Jude Children Research Hospital
  • University of Tennessee System
  • Virginia Commonwealth University
  • Texas Children's Cancer Center and Hematology Service
  • City of Hope National Medical Center
  • Mayo Clinic
  • Washington University St. Louis
  • Northwestern University
  • University of Michigan, Ann Arbor
  • Cornell University
  • University of California at Los Angeles
  • University of Texas Medical Branch at Galveston
  • National Comprehensive Cancer Network

Research output: Contribution to journalReview articlepeer-review

559 Scopus citations

Abstract

Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.

Original languageEnglish
Pages (from-to)536-563
Number of pages28
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume16
Issue number5
DOIs
StatePublished - May 1 2018

Keywords

  • Guidelines as Topic/standards
  • Humans
  • Medical Oncology/methods
  • Sarcoma/diagnosis

Fingerprint

Dive into the research topics of 'Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this